Deferred Tax Assets, Operating Loss Carryforwards of Advanced Biomed Inc. from 30 Jun 2024 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Advanced Biomed Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 30 Jun 2024 to 31 Dec 2025.
  • Advanced Biomed Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Dec 2025 was $1,695,405, a 18% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

Advanced Biomed Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,695,405 -$373,374 -18% 31 Dec 2025 10-Q 13 Feb 2026 2026 Q2
Q3 2025 $2,929,756 30 Sep 2025 10-Q 19 Nov 2025 2026 Q1
Q2 2025 $919,091 -$1,100,617 -54% 30 Jun 2025 10-Q 13 Feb 2026 2026 Q2
Q1 2025 $2,441,045 31 Mar 2025 10-Q 15 May 2025 2025 Q3
Q4 2024 $2,068,779 31 Dec 2024 10-Q 15 Apr 2025 2025 Q2
Q2 2024 $2,019,708 30 Jun 2024 10-K 08 Oct 2025 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.